JP Morgan Chase’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,924
| Closed | -$3.77K | – | 7866 |
|
|
2023
Q2 | $3.77K | Hold |
3,924
| – | – | ﹤0.01% | 6225 |
|
|
2023
Q1 | $3K | Hold |
3,924
| – | – | ﹤0.01% | 6378 |
|
|
2022
Q4 | $1K | Sell |
3,924
-7,821
| -67% | -$3.3K | ﹤0.01% | 6482 |
|
|
2022
Q3 | $5K | Sell |
11,745
-32,131
| -73% | -$31.6K | ﹤0.01% | 6114 |
|
|
2022
Q2 | $34K | Sell |
43,876
-397,736
| -90% | -$351K | ﹤0.01% | 5767 |
|
|
2022
Q1 | $571K | Sell |
441,612
-50,044
| -10% | -$46.1K | ﹤0.01% | 4622 |
|
|
2021
Q4 | $624K | Sell |
491,656
-29,360
| -6% | -$52.5K | ﹤0.01% | 4692 |
|
|
2021
Q3 | $1.14M | Sell |
521,016
-39,204
| -7% | -$107K | ﹤0.01% | 4213 |
|
|
2021
Q2 | $2.1M | Sell |
560,220
-66,307
| -11% | -$230K | ﹤0.01% | 3757 |
|
|
2021
Q1 | $2.04M | Sell |
626,527
-3,537
| -0.6% | -$12.7K | ﹤0.01% | 3711 |
|
|
2020
Q4 | $2.15M | Sell |
630,064
-139,009
| -18% | -$572K | ﹤0.01% | 3428 |
|
|
2020
Q3 | $3.21M | Buy |
769,073
+622,346
| +424% | +$2.37M | ﹤0.01% | 2909 |
|
|
2020
Q2 | $496K | Sell |
146,727
-100
| -0.1% | -$291 | ﹤0.01% | 3853 |
|
|
2020
Q1 | $341K | Sell |
146,827
-23,110
| -14% | -$63.3K | ﹤0.01% | 4025 |
|
|
2019
Q4 | $619K | Sell |
169,937
-3,814
| -2% | -$30.8K | ﹤0.01% | 4128 |
|
|
2019
Q3 | $1.44M | Sell |
173,751
-63,785
| -27% | -$516K | ﹤0.01% | 3621 |
|
|
2019
Q2 | $2.07M | Buy |
237,536
+4,697
| +2% | +$42K | ﹤0.01% | 3358 |
|
|
2019
Q1 | $2.49M | Sell |
232,839
-8,874
| -4% | -$95K | ﹤0.01% | 3188 |
|
|
2018
Q4 | $2.12M | Buy |
241,713
+215,290
| +815% | +$2.74M | ﹤0.01% | 3236 |
|
|
2018
Q3 | $444K | Buy |
26,423
+3,628
| +16% | +$78.5K | ﹤0.01% | 4334 |
|
|
2018
Q2 | $477K | Sell |
22,795
-161,456
| -88% | -$2.99M | ﹤0.01% | 4200 |
|
|
2018
Q1 | $2.96M | Sell |
184,251
-103,714
| -36% | -$2.05M | ﹤0.01% | 2997 |
|
|
2017
Q4 | $5.46M | Buy |
287,965
+235,224
| +446% | +$4.26M | ﹤0.01% | 2617 |
|
|
2017
Q3 | $712K | Buy |
52,741
+50,661
| +2,436% | +$458K | ﹤0.01% | 3688 |
|
|
2017
Q2 | $15K | Buy |
2,080
+305
| +17% | +$1.99K | ﹤0.01% | 4595 |
|
|
2017
Q1 | $12K | Buy |
1,775
+215
| +14% | +$1.2K | ﹤0.01% | 4792 |
|
|
2016
Q4 | $7K | Buy |
+1,560
| New | +$6.54K | ﹤0.01% | 4844 |
|
|
2016
Q3 | – | Sell |
-66
| Closed | – | – | 4891 |
|
|
2016
Q2 | $0 | Hold |
66
| – | – | ﹤0.01% | 5026 |
|
|
2016
Q1 | $0 | Buy |
+66
| New | +$339 | ﹤0.01% | 5014 |
|
|
2013
Q4 | – | Sell |
-111,453
| Closed | -$934K | – | 4286 |
|
|
2013
Q3 | $934K | Sell |
111,453
-29,647
| -21% | -$240K | ﹤0.01% | 3311 |
|
|
2013
Q2 | $1.05M | Buy |
+141,100
| New | +$1.08M | ﹤0.01% | 3226 |
|
JP Morgan Chase's SPPI Position: Q3 2023 in Review
JP Morgan Chase sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 3,924 shares — an estimated $3.77K sold.
JP Morgan Chase first reported a position in SPPI in Q2 2013 and held it in 31 quarters. The position peaked at $5.46M in Q4 2017. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- JP Morgan Chase reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- JP Morgan Chase sold 3,924 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $3.77K.
- JP Morgan Chase first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
- JP Morgan Chase's Spectrum Pharmaceuticals Inc position peaked at $5.46M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.